A Study to Evaluate Safety and Efficacy of ASP015K in Patients With Rheumatoid Arthritis (RA) Who Had an Inadequate Response to DMARDs
Clinical trial NCT02308163 · COMPLETED
Trial details
- NCT number
- NCT02308163
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-08
- Primary completion
- 2017-01-23
- Enrollment
- 509
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.